BioSpace News Archive

DBV Technologies announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May.

The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce several new offerings as part of its Certified Advanced Biotherapies Professional (CABP)

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held in a virtual-only setting.

Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, announced that Matthew Roden, Ph.D., President and Chief Executive Officer, will be presenting at the 2024 Guggenheim Healthcare Talks Radiopharmaceuticals Day, being held Monday, May 13, 2024, in New York City.

Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) (“Scryb’’ or the “Company”), is pleased to announce that, further to its press release of April 1, 2024, the Company’s

23andMe Holding Co., a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced that it will report financial results for the fourth quarter and full fiscal year 2024 after the market closes on Thursday, May 23, 2024.

Zomedica Corp., a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, reported consolidated financial results for the first quarter ended March 31, 2024.

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time.

Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, reported financial results for the three months ended March 31, 2024, and provided a business update.

Rakuten Medical, Inc today announced that it will present a poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (ASCO 2024), which will be held in Chicago, Illinois from May 31 through June 4, 2024.